A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

被引：0
|
作者：
Ma, K. [1 ]
Xu, Y. [1 ]
Cai, Y. [1 ]
Wang, X. [1 ]
Sun, C. [1 ]
Guo, Y. [1 ]
Qiu, S. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
small-cell lung cancer; Apatinib; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP10.05
引用
收藏
页码：S216 / S217
页数：2
相关论文
共 50 条
  • [21] Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Mazzanti, P
    Massacesi, C
    Rocchi, MBL
    Mattioli, R
    Lippe, P
    Trivisonne, R
    Buzzi, F
    De Signoribus, G
    Tuveri, G
    Rossi, G
    Di Lullo, L
    Sturba, F
    Morale, D
    Catanzani, S
    Pilone, A
    Bonsignori, M
    Battelli, T
    LUNG CANCER, 2003, 41 (01) : 81 - 89
  • [22] Phase I Study of Apatinib Plus Gefitinib as First-Line Therapy in Patients with EGFR Mutant Advanced NonSmall Cell Lung Cancer
    Zhao, H.
    Zhang, Z.
    Li, S.
    Fang, W.
    Ma, Y.
    Zhang, Y.
    Yang, Y.
    Luo, F.
    Huang, Y.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S506 - S506
  • [23] Phase II Trial of Apatinib Plus Chemotherapy for Second-Line and Above Treatment of Advanced SCLC: Focus on Efficacy and Safety
    Ma, K.
    Xu, Y.
    Wang, X.
    Cai, Y.
    Sun, C.
    Guo, Y.
    Qiu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S539 - S539
  • [24] Apatinib plus icotinib in treating advanced non small cell lung cancer after icotinib treatment failure: a retrospective study
    Xu, Jianping
    Liu, Xiaoyan
    Yang, Sheng
    Zhang, Xiangru
    Shi, Yuankai
    ONCOTARGETS AND THERAPY, 2017, 10 : 4989 - 4995
  • [25] Apatinib plus chemotherapy versus chemotherapy alone as neoadjuvant therapy in locally advanced gastric carcinoma patients: a prospective, cohort study
    Sun, Yun
    Fan, Yanan
    Ye, Zhibin
    Dong, Jiantao
    Zhang, Lifei
    Peng, Yanhui
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1033 - 1040
  • [26] Apatinib as an Alternative for Advanced Non-Small Cell Lung Cancer
    Wu, Z.
    Pan, H.
    Ye, M.
    Chen, L.
    Qian, W.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S715 - S715
  • [27] Neoadjuvant PD-1 inhibitor plus apatinib and chemotherapy versus apatinib plus chemotherapy versus chemotherapy alone in patients with locally advanced gastric cancer
    Xiong, Hui
    Li, Yun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (08): : 3559 - 3570
  • [28] Apatinib plus chemotherapy versus chemotherapy alone as neoadjuvant therapy in locally advanced gastric carcinoma patients: a prospective, cohort study
    Yun Sun
    Yanan Fan
    Zhibin Ye
    Jiantao Dong
    Lifei Zhang
    Yanhui Peng
    Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1033 - 1040
  • [29] Observation on the Clinical Effect of Apatinib Combined with Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer
    Cui, Yu-jie
    Liu, Jia
    Liu, Miao-miao
    Zhang, Hong-zhen
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (04) : 1036 - 1041
  • [30] Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer
    Miller, Antonius A.
    Case, Doug
    Atkins, James N.
    Giguere, Jeffrey K.
    Bearden, James D.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) : 832 - 836
12345